Lupin Launches Higher Mirabegron Dose ‘At-Risk’
The 25mg Dose Was Launched Back In April, Also ‘At-Risk’
Lupin and Zydus have established a two-player market for their generic versions of mirabegron, while patent litigation with originator Astellas continues on.
